The latest brain, head and neck cancer news
Genetic changes in neuroblastoma leading to tumour evolution
Tumours are heterogeneous, which means that different parts of the same tumour can be genetically…
Browsing: Neuro-oncology, Head and Neck Cancers
Which glioblastoma patients will respond to immunotherapy?
Northwestern Medicine (USA) scientists have discovered a new biomarker to identify which patients with glioblastomas…
Saliva testing may allow early detection of human papillomavirus–driven head and neck cancers
Cancer causing high-risk human papillomaviruses (HR-HPV) are responsible for the rising incidence of HR-HPV–driven head…
ESMO 2021: CheckMate 651 study
Highlights on nivolumab plus ipilimumab vs EXTREME in 1st-line high-risk squamous cell carcinoma of the…
Immunotherapy for HPV positive head and neck cancer: Awakening the force within
A new study from scientists at Emory Vaccine Center and Winship Cancer Institute of Emory…
HPV vaccination will reduce throat and mouth cancers, but will take 25-plus years to see
Vaccinations against human papillomavirus (HPV), a major cause of throat and back of mouth cancers,…
Targeting brain cancer at its root
McGill University (USA) researchers identify proteins that drive cancer stem cells. Targeting and suppressing a…
Genetic profile of tumour can indicate best treatment for brain cancer patients
Researchers at the Center for Cell-Based Therapy (CTC), USA, have discovered a set of biomarkers…
Prototype magnetic helmet shrinks aggressive brain cancer in world-first case
All cancer is nasty, but some forms are nastier than others. Take glioblastoma, a thankfully rare…
World-first trial tests cannabis-based drug on aggressive brain tumours
A major UK trial of cannabis-based drug Sativex in treating the most aggressive form of…